跳至主要内容
临床试验/ACTRN12612001038886
ACTRN12612001038886招募中未知

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in selected districts of Nepal

Ministry of Health and Population, Nepal0 个研究点目标入组 270 人开始时间: 2012年9月28日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
6 Months 至 o limit(—)
性别
All

入选标准

  • Patients above 6 months, except girls between 12-18 years and unmarried women above 18 years
  • Malaria positive p. falciparum mono-infection with a parasite density of 1'000-100'000 parasites per microliter
  • Axillary temperature of 37.5 C or greater or history of fever during the past 24 hours
  • Ability to swallow oral medication
  • Ability to comply with study procedures
  • Written informed consent from patient or from parent or leagl guardian in case of children

排除标准

  • Presence general danger signs of severe and complicated malaria
  • Mixed or mono-infection with another Plasmodium species
  • Severe malnutrition
  • Febrile conditions due to disease other than malaria
  • Regular medication, whcih may interfere with antimalarial pharmacokinetics.
  • History of hypersensitivity reactions to the medicinal products
  • preganancy or breastfeeding
  • Girls between 12-18 years, or unamrried women above 18 years
  • Women unable or unwilling to take contraceptives

研究者

发起方
Ministry of Health and Population, Nepal

相似试验